Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Santa Maria da Feira
Clinical trial register · Portugal

Clinical Trials in Santa Maria da Feira, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Portugal and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1104 matching records held by the registry are in this view. Synced 30 Oct 2026, 03:17 UTC
1104
Studies in scope
all four open statuses
533
Recruiting now
open to new participants
285
Lead sponsors
across recruiting studies
Top sites
Lisbon 689 Porto 537 Coimbra 256 Braga 182 Vila Nova de Gaia 105
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hoffmann-La Roche7 Janssen Research & Development, LLC6 AbbVie3 Novartis Pharmaceuticals3 Xenon Pharmaceuticals Inc.3
Site location
Lisbon689 Porto537 Coimbra256 Braga182 Vila Nova de Gaia105
All 97 locations
Target enrolment
to

Trials with a site in Santa Maria da Feira

37 of 1104 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Portugal
Start
Not yet open
Universidade do Porto
Phase 3
70
Porto, Santa Maria da Feira
2027-01
Not yet open
Family-centred Pulmonary Rehabilitation to Empower Carers
NCT07791147Pulmonary Disease, Chronic Obstructive, Lung Diseases, Interstitial, Asthma, Lung Neoplasms
Aveiro University
Not applicable
120
Aveiro, Santa Maria da Feira, Figueira da Foz Municipality, Lisbon, Matosinhos Municipality, Vila Nova de Gaia
2026-09
Recruiting
Hospital de Sao Sebastiao
Not applicable
72
Santa Maria da Feira
2026-04-20
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
DrugZotemtegrast
Eli Lilly and Company
Phase 2
1,431
Braga, Lisbon, Santa Maria da Feira
2026-03-26
Recruiting
Hoffmann-La Roche
Phase 2
360
Braga, Coimbra, Lisbon, Santa Maria da Feira
2026-03-10
Recruiting
Hoffmann-La Roche
Phase 3
425
Braga, Lisbon, Porto, Santa Maria da Feira, Viseu
2025-05-12
Recruiting
Hoffmann-La Roche
Phase 3
600
Braga, Lisbon, Porto, Santa Maria da Feira, Viseu
2025-03-17
Active, closed
Sanofi
Phase 3
231
Guimarães, Matosinhos Municipality, Porto, Santa Maria da Feira
2025-02-12
Active, closed
Hoffmann-La Roche
Phase 3
350
Braga, Lisbon, Portimão, Porto, Santa Maria da Feira, Viseu
2024-12-11
Active, closed
Hoffmann-La Roche
Phase 3
400
Braga, Lisbon, Portimão, Porto, Santa Maria da Feira, Viseu
2024-09-17
Active, closed
Nursing Practice Environment and Patient Safety in Primary Health Care
NCT06762015Healthy Work Environment, Patient Safety, Primary Health Care
Cintia Silva Fassarella
Not applicable
45
Santa Maria da Feira
2024-09-02
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Santa Maria da Feira, Senhora da Hora, Braga, Coimbra, Lisbon
2024-07-30
Recruiting
Amgen
Phase 3
450
Almada, Coimbra, Lisbon, Matosinhos Municipality, Santa Maria da Feira
2024-07-17
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Santa Maria da Feira, Senhora da Hora, Braga, Lisbon
2024-05-13
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Braga, Coimbra, Lisbon, Matosinhos Municipality, Santa Maria da Feira
2024-04-16
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
360
Coimbra, Guimarães, Lisbon, Porto, Santa Maria da Feira, Vila Real
2023-05-09
By invitation
An Open-label Study of XEN1101 in Epilepsy
NCT05718817Focal Epilepsy, Tonic-Clonic Seizures
DrugAzetukalner
Xenon Pharmaceuticals Inc.
Phase 3
880
Coimbra, Guimarães, Lisbon, Porto, Santa Maria da Feira
2023-04-25
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Coimbra, Covilha, Figueira da Foz Municipality, Lisbon, Santa Maria da Feira, Torres Novas, Vila Nova de Gaia, Vila Real
2023-04-11
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Almada, Carnaxide, Coimbra, Lisbon, Matosinhos Municipality, Porto, Santa Maria da Feira, Setúbal
2023-03-09
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Braga, Coimbra, Covilha, Guimarães, Lisbon, Porto, Pragal, Santa Maria da Feira
2023-02-15
Recruiting
Xenon Pharmaceuticals Inc.
Phase 3
160
Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Porto, Santa Maria da Feira
2023-02-14
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Aveiro, Lisbon, Porto, Santa Maria da Feira
2022-12-13
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Lisbon, Loures, Portimão, Santa Maria da Feira, Vila Nova de Gaia
2022-09-19
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Lisbon, Portimão, Porto, Santa Maria da Feira
2022-07-22
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Braga, Coimbra, Leiria, Lisbon, Matosinhos Municipality, Santa Maria da Feira
2021-12-13
Active, closed
Hoffmann-La Roche
Phase 1
119
Braga, Lisbon, Santa Maria da Feira
2021-08-11
Active, closed
Hoffmann-La Roche
Phase 3
746
Braga, Coimbra, Lisbon, Porto, Santa Maria da Feira
2021-03-17
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Almada, Braga, Coimbra, Guimarães, Lisbon, Loures, Porto, Santa Maria da Feira
2021-02-23
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Lisbon, Porto, Santa Maria da Feira
2020-11-12
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Coimbra, Porto, Santa Maria da Feira, Viseu
2019-09-26
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Braga, Coimbra, Lisbon, Loures, Matosinhos Municipality, Porto, Santa Maria da Feira
2018-12-28
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
507
Braga, Coimbra, Guimarães, Lisbon, Porto, Santa Maria da Feira, Setúbal, Vila Real
2018-11-28
Active, closed
AbbVie
Phase 3
1,242
Guimarães, Portimão, Santa Maria DA Feira, Almada, Coimbra, Lisbon, Porto, Viseu
2018-08-28
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Braga, Coimbra, Guimarães, Portimão, Porto, Santa Maria da Feira
2018-04-13
Active, closed
AbbVie
Phase 3
1,336
Guimarães, Portimão, Lisbon, Santa Maria DA Feira, Almada, Faro, Loures, Porto
2018-04-09
Active, closed
AbbVie
Phase 3
950
Guimarães, Santa Maria DA Feira, Almada, Braga, Lisbon, Porto, Viana do Castelo
2017-01-31
Recruiting
Manuel Monreal
Observational
120,000
Vila Nova de Famalicão, Senhora da Hora, Porto, Santa Maria da Feira, Almada, Vila Nova de Gaia
2001-03
Rows per page Showing 1–37 of 37
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Portuguese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 31 October 2026. https://priyalifescience.com/clinical-trials-portugal/city/santa-maria-da-feira

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Portugal and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,104 studies in total at the last sync on 30 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 37 of those studies with a site in Santa Maria da Feira.

How many clinical trials are recruiting in Santa Maria da Feira?

9 of the 37 studies on this page are recruiting new participants as of the 30 Oct 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 24 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Santa Maria da Feira), 37 studies
PhaseStudiesRecruitingShare
Phase 324564.9%
Phase 25213.5%
Not applicable318.1%
Phase 2/3308.1%
Observational112.7%
Phase 1102.7%

Most active sponsors

Lead sponsors with the most studies (Santa Maria da Feira)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche73
Janssen Research & Development, LLC60
AbbVie30
Novartis Pharmaceuticals30
Xenon Pharmaceuticals Inc.32
Biohaven Therapeutics Ltd.20
Sanofi20
Amgen11
Astellas Pharma Global Development, Inc.10
Aveiro University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.